BDTX
Black Diamond Therapeutics Inc
1.90$
+2.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | +13,465.9% | -100.0% | – | – | – | – | – | |
| – | -89.6% | +0.0% | +0.0% | +0.0% | – | – | – | – | – | -59.1% | – | – | |
| – | – | – | – | – | – | +27,031.8% | -100.1% | – | – | – | – | – | |
| – | -5.4% | -12.0% | -7.3% | +3.6% | -4.8% | -14.6% | -11.3% | -20.2% | -15.3% | +11.2% | +5.6% | – | |
| – | -29.2% | +20.4% | +42.9% | -45.5% | +14.6% | -17.0% | -17.4% | -13.7% | +12.0% | +7.3% | +9.6% | – | |
| – | -13.1% | -3.3% | +9.3% | -17.8% | +0.8% | -15.3% | -13.8% | -17.7% | +60.4% | -36.1% | +7.1% | – | |
| – | – | – | – | – | – | – | -124.6% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -118.7% | – | – | – | – | – | |
| – | – | -96.8% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -118.7% | – | – | – | – | – | |
| – | – | – | – | – | – | – | -118.5% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.